Greg A. Gerhardt

Overview

Best Publications

• Functional recovery in parkinsonian monkeys treated with GDNF.

  D M Gash;Z Zhang;A Ovadia;W A Cass

  1182
  Citations

• Nafion-coated electrodes with high selectivity for CNS electrochemistry.

  Greg A. Gerhardt;Arvin F. Oke;Geza Nagy;Bita Moghaddam

  759
  Citations

• Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line—derived neurotrophic factor

  John T. Slevin;Greg A. Gerhardt;Charles D. Smith;Don M. Gash

  557
  Citations

• Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.

  John L. Hudson;Craig G. van Horne;Ingrid Strömberg;Scot Brock

  541
  Citations

• Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo.

  Barry J. Hoffer;Alex Hoffman;Kate Bowenkamp;Peter Huettl

  540
  Citations

• Neurobiological Studies of Sensory Gating in Schizophrenia

  Robert Freedman;Lawrence E. Adler;Greg A. Gerhardt;Merilyne Waldo

  520
  Citations

• Caloric restriction increases neurotrophic factor levels and attenuates neurochemical and behavioral deficits in a primate model of Parkinson's disease

  Navin Maswood;Jennifer Young;Edward Tilmont;Zhiming Zhang

  450
  Citations

• Self-Referencing Ceramic-Based Multisite Microelectrodes for the Detection and Elimination of Interferences from the Measurement of l-Glutamate and Other Analytes

  Jason J. Burmeister;Greg A. Gerhardt

  411
  Citations

• o-Phenylenediamine-modified carbon fiber electrodes for the detection of nitric oxide.

  Marilyn N. Friedemann;Scott W. Robinson;Greg A. Gerhardt

  382
  Citations

• Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level

  Saloua Benmansour;Marco Cecchi;David A Morilak;Greg A. Gerhardt

  375
  Citations

• Glial Cell Line-Derived Neurotrophic Factor Supports Survival of Injured Midbrain Dopaminergic Neurons

  Kathryn E. Bowenkamp;Alexander F. Hoffman;Greg A. Gerhardt;Michael A. Henry

  361
  Citations

• Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys

  Richard Grondin;Zhiming Zhang;Ai Yi;Wayne A. Cass

  353
  Citations

• Improved ceramic-based multisite microelectrode for rapid measurements of L-glutamate in the CNS.

  Jason J Burmeister;Francois Pomerleau;Michael Palmer;Brian K Day

  327
  Citations

• Critical decline in fine motor hand movements in human aging

  C.D. Smith;G.H. Umberger;E.L. Manning;J.T. Slevin

  316
  Citations

• Dopamine D2 Receptor‐Deficient Mice Exhibit Decreased Dopamine Transporter Function but No Changes in Dopamine Release in Dorsal Striatum

  Shelly D. Dickinson;Jilla Sabeti;Gaynor A. Larson;Karen Giardina

  306
  Citations

• Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo

  John Hudson;Ann Charlotte Granholm;Greg A. Gerhardt;Michael A. Henry

  304
  Citations

• Determination of diffusion coefficients by flow injection analysis

  Greg. Gerhardt;Ralph N. Adams

  296
  Citations

• Point source concentration of GDNF may explain failure of phase II clinical trial.

  Michael Francis Salvatore;Yi Ai;Brent Fischer;Amanda M. Zhang

  278
  Citations

• Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake

  Wayne A. Cass;Greg A. Gerhardt

  267
  Citations

• Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity.

  Don M. Gash;Kathryn Rutland;Naomi L. Hudson;Patrick G. Sullivan

  260
  Citations

• Regional effects of aging on dopaminergic function in the Fischer-344 rat.

  Marilyn N. Friedemann;Greg A. Gerhardt

  251
  Citations